Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Oral Oncol ; 55: 24-30, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26874554

ABSTRACT

OBJECTIVES: Assessment of long-term objective and subjective voice, speech, articulation, and quality of life in patients with head and neck cancer (HNC) treated with concurrent chemoradiotherapy (CRT) for advanced, stage IV disease. MATERIALS AND METHODS: Twenty-two disease-free survivors, treated with cisplatin-based CRT for inoperable HNC (1999-2004), were evaluated at 10-years post-treatment. A standard Dutch text was recorded. Perceptual analysis of voice, speech, and articulation was conducted by two expert listeners (SLPs). Also an experimental expert system based on automatic speech recognition was used. Patients' perception of voice and speech and related quality of life was assessed with the Voice Handicap Index (VHI) and Speech Handicap Index (SHI) questionnaires. RESULTS: At a median follow-up of 11-years, perceptual evaluation showed abnormal scores in up to 64% of cases, depending on the outcome parameter analyzed. Automatic assessment of voice and speech parameters correlated moderate to strong with perceptual outcome scores. Patient-reported problems with voice (VHI>15) and speech (SHI>6) in daily life were present in 68% and 77% of patients, respectively. Patients treated with IMRT showed significantly less impairment compared to those treated with conventional radiotherapy. CONCLUSION: More than 10-years after organ-preservation treatment, voice and speech problems are common in this patient cohort, as assessed with perceptual evaluation, automatic speech recognition, and with validated structured questionnaires. There were fewer complaints in patients treated with IMRT than with conventional radiotherapy.


Subject(s)
Chemoradiotherapy/adverse effects , Head and Neck Neoplasms/therapy , Quality of Life , Speech Disorders/etiology , Voice Quality , Adult , Aged , Antineoplastic Agents/adverse effects , Cisplatin/adverse effects , Female , Humans , Male , Middle Aged , Radiotherapy, Intensity-Modulated/adverse effects , Randomized Controlled Trials as Topic , Severity of Illness Index , Surveys and Questionnaires , Treatment Outcome , Voice Quality/drug effects , Voice Quality/radiation effects
2.
Oral Oncol ; 51(8): 787-94, 2015 Aug.
Article in English | MEDLINE | ID: mdl-26027851

ABSTRACT

OBJECTIVES: Assessment of long term (10-years+) swallowing function, mouth opening, and quality of life (QoL) in head and neck cancer (HNC) patients treated with chemo-radiotherapy (CRT) for advanced stage IV disease. MATERIALS AND METHODS: Twenty-two disease-free survivors, participating in a multicenter randomized clinical trial for inoperable HNC (1999-2004), were evaluated to assess long-term morbidity. The prospective assessment protocol consisted of videofluoroscopy (VFS) for obtaining Penetration Aspiration Scale (PAS) and presence of residue scores, Functional Oral Intake Scale (FOIS) scores, maximum mouth opening measurements, and (SWAL-QOL and study-specific) questionnaires. RESULTS: At a median follow-up of 11-years, 22 patients were evaluable for analysis. Ten patients (46%) were able to consume a normal oral diet without restrictions (FOIS score 7), whereas 12 patients (54%) had moderate to serious swallowing issues, of whom 3 (14%) were feeding tube dependent. VFS evaluation showed 15/22 patients (68%) with penetration and/or aspiration (PAS⩾3). Fifty-five percent of patients (12/22) had developed trismus (mouth opening⩽35mm), which was significantly associated with aspiration (p=.011). Subjective swallowing function (SWAL-QOL score) was impaired across almost all QoL domains in the majority of patients. Patients treated with IMRT showed significantly less aspiration (p=.011), less trismus (p=.035), and less subjective swallowing problems than those treated with conventional radiotherapy. CONCLUSION: Functional swallowing and mouth opening problems are substantial in this patient cohort more than 10-years after organ-preservation CRT. Patients treated with IMRT had less impairment than those treated with conventional radiotherapy.


Subject(s)
Carcinoma, Squamous Cell/therapy , Chemoradiotherapy/adverse effects , Deglutition Disorders/epidemiology , Head and Neck Neoplasms/therapy , Radiation Injuries/epidemiology , Trismus/epidemiology , Adult , Aged , Deglutition Disorders/etiology , Female , Humans , Male , Middle Aged , Multicenter Studies as Topic , Quality of Life , Radiotherapy, Intensity-Modulated/adverse effects , Randomized Controlled Trials as Topic , Surveys and Questionnaires , Treatment Outcome , Trismus/etiology
3.
Dysphagia ; 30(4): 392-403, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25840788

ABSTRACT

Head and neck cancer (HNC) patients may develop dysphagia due to muscle atrophy and fibrosis following chemoradiotherapy. Strengthening of the swallowing muscles through therapeutic exercise is potentially effective for improving swallowing function. We hypothesize that a customized Swallow Exercise Aid (SEA), developed for isometric and isokinetic strengthening exercises (against resistance), can help to functionally strengthen the suprahyoid musculature, which in turn can improve swallowing function. An effectiveness/feasibility study was carried out with ten senior healthy volunteers, who performed exercises 3 times per day for 6 weeks. Exercises included chin tuck against resistance (CTAR), jaw opening against resistance (JOAR), and effortful swallow exercises with the SEA. Multidimensional assessment consisted of measurements of maximum chin tuck and jaw opening strength, maximum tongue strength/endurance, suprahyoid muscle volume, hyoid bone displacement, swallowing transport times, occurrence of laryngeal penetration/aspiration and/or contrast residue, maximum mouth opening, feasibility/compliance (questionnaires), and subjective swallowing complaints (SWAL-QOL). After 6-weeks exercise, mean chin tuck strength, jaw opening strength, anterior tongue strength, suprahyoid muscle volume, and maximum mouth opening significantly increased (p < .05). Feasibility and compliance (median 86 %, range 48-100 %) of the SEA exercises were good. This prospective effectiveness/feasibility study on the effects of CTAR/JOAR isometric and isokinetic strengthening exercises on swallowing musculature and function shows that senior healthy subjects are able to significantly increase swallowing muscle strength and volume after a 6-week training period. These positive results warrant further investigation of effectiveness and feasibility of these SEA exercises in HNC patients with dysphagia.


Subject(s)
Deglutition Disorders/physiopathology , Deglutition Disorders/therapy , Deglutition , Exercise Therapy , Aged , Deglutition Disorders/pathology , Exercise Therapy/instrumentation , Feasibility Studies , Healthy Volunteers , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Muscle Strength , Prospective Studies , Tongue
4.
Curr Opin Support Palliat Care ; 8(2): 152-63, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24743298

ABSTRACT

PURPOSE OF REVIEW: Dysphagia, or swallowing impairment, is a serious sequel of head and neck cancer (HNC) and its treatment. This review focuses on the rapidly growing literature published during the past 2 years about the current assessment and treatment strategies of dysphagia in HNC patients. RECENT FINDINGS: Functional swallowing assessment has become standard of care in many HNC centers, to prevent or identify (silent) aspiration, to optimize functional outcomes, and to determine the appropriate rehabilitation strategy. Also preventive swallowing exercises are considered more and more in the pretreatment setting with promising results on (pharyngeal) swallowing function. However, there is a lack of consensus regarding type, frequency, or intensity of the exercises. Furthermore, long-term follow-up of swallowing function might be necessary, given the potential for long-term sequels following HNC treatment. SUMMARY: Regarding dysphagia evaluation, there is still a lack of a uniform 'gold-standard' for both assessment and treatment strategies. More high-quality data, adequately controlled, adequately powered and randomized, on prophylactic and therapeutic swallowing exercises are needed, with longer follow-up and better adherence to treatment, for better understanding the effects of chemo and radiotherapy dosage, and of frequency, timing and duration of treatment, to improve swallowing function and optimize quality of life.


Subject(s)
Deglutition Disorders/etiology , Deglutition Disorders/rehabilitation , Exercise Therapy/methods , Head and Neck Neoplasms/complications , Deglutition , Deglutition Disorders/psychology , Head and Neck Neoplasms/psychology , Head and Neck Neoplasms/radiotherapy , Humans , Patient Care Team , Quality of Life
SELECTION OF CITATIONS
SEARCH DETAIL
...